SR ONE CAPITAL MANAGEMENT, LP — 13F holdings

SR ONE CAPITAL MANAGEMENT, LP reported 15 holdings worth $1.04B in its 13F filing for Q2 2026, filed August 12, 2026.

Largest positions

1. MANE VERADERMICS INC — $295M (28.4%)
2. ZBIO ZENAS BIOPHARMA INC — $128M (12.3%)
3. CRSP CRISPR Therapeutics AG — $111M (10.7%)
4. AVLN AVALYN PHARMACEUTICALS INC — $109M (10.5%)
5. DSGN DESIGN THERAPEUTICS INC — $94.4M (9.1%)
6. ODTX ODYSSEY THERAPEUTICS INC — $71.0M (6.8%)
7. ALMS ALUMIS INC — $55.2M (5.3%)
8. ORIC ORIC PHARMACEUTICALS INC — $50.0M (4.8%)
9. MLYS MINERALYS THERAPEUTICS INC — $42.2M (4.1%)
10. SPRY ARS PHARMACEUTICALS INC — $32.1M (3.1%)